Abstract
With the westernization of lifestyle in people all over the world, especially in advanced countries in recent years, dietary intake of magnesium via grain, barley, seaweed, vegetable, and nuts has remarkably diminished. As a result, people may more easily develop hypomagnesemia. Likewise, metabolic syndrome has been an increasing problem for health, probably resulting from various causes such as increased intake of animal fat, exercise insufficiency, and accumulation of various stresses. Metabolic syndrome is often complicated with obesity, hypertension, hyperglycemia, and hyperlipidemia, and thus people with the syndrome may be susceptible to cardiovascular events. Hypomagnesemia may cause an increase of vascular tonus by intracellular magnesium depletion, resulting in an increase of blood pressure. Furthermore, it might cause impaired insulin secretion, insulin resistance, and hyperlipidemia, and finally lead to the development of metabolic syndrome. Therefore, the importance of magnesium intake for the maintenance of health should be recognized.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595–1607.
Kaplan NM. The deadly quartet. Arch Int Med 1989;149:1514–1520.
DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173–194.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult T reatment P anel I II). JAMA 2001;285:2486–2497.
Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782–787.
Guerrero-Romero F, Rodriguez-Moran M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002;39:209–213.
Altura BM, Altura BT. Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res 1995;41:347–359.
Ma J, Folsom AR, Melnick SL, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995;48:927–940.
Legrand C, Okitolonda W, Pottier AM, et al. Glucose homeostasis in magnesiumdeficient rats. Metabolism 1987;36:160–164.
Polisso G, Barbagallo M. Hypertension, diabetes mellitus and insulin resistance. The role of intracellular magnesium. Am J Hypertens 1997;10:346–355.
McKeown NM. Whole grain intake and insulin sensitivity: evidence from observational studies. Nutr Rev 2004;62:286–291.
Morrill GA, Gupta RK, Kostellow AB, et al. Mg2+ modulates membrane lipids in vascular smooth muscle: a link to atherogenesis. FEBS Lett 1997;408:191–194.
Rayssiguier Y, Gueux E. Magnesium and lipids in cardiovascular disease. J Am Coll Nutr 1986;5:507–519.
Altura BT, Brust M, Bloom S, et al. Magnesium dietary intake modulates blood lipid levels and atherosclerosis. Proc Natl Acad Sci U S A 1990;87:1840–1844.
Lal J, Vasudev K, Kela AK, et al. Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus. J Assoc Physicians India 2003;51:37–42.
Hsieh ST, Sano H, Saito K, et al. Magnesium supplementation prevents the development of alcohol-induced hypertension. Hypertension 1992;19:175–182.
Delpiano MA, Altura BM. Modulatory effect of extracellular Mg2+ ions on K+ and Ca2+ currents of capillary endothelial cells from rat brain. FEBS Lett 1996;394:335–339.
Paolisso G, Barbagallo M. Hypertensions, diabetes mellitus and insulin resistance. The role of intracellular magnesium. Am J Hypertens 1997;10:346–355.
Shimosawa T, Takano K, Ando K, et al. Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings. Hypertension 2004;44:897–902.
Huerta MG, Roemmich JN, Kington ML, et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care 2005;28:1175–1181.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag London Limited
About this chapter
Cite this chapter
Kumeda, Y., Inaba, M. (2007). Review of Magnesium and Metabolic Syndrome. In: Nishizawa, Y., Morii, H., Durlach, J. (eds) New Perspectives in Magnesium Research. Springer, London. https://doi.org/10.1007/978-1-84628-483-0_15
Download citation
DOI: https://doi.org/10.1007/978-1-84628-483-0_15
Publisher Name: Springer, London
Print ISBN: 978-1-84628-388-8
Online ISBN: 978-1-84628-483-0
eBook Packages: MedicineMedicine (R0)